You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

v600-mutation

Showing 1 - 25 of 7,373
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

Not yet recruiting
  • NSCLC
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University
Sep 19, 2023

Cancer, BRAF V600 Mutation, Melanoma Trial (XP-102, Trametinib)

Not yet recruiting
  • Cancer
  • +5 more
  • (no location specified)
Aug 18, 2022

BRAF V600-mutated Lung Carcinoma Treated With Combination of

Completed
  • Non Small Cell Lung Cancer
  • BRAF V600 Mutation
    • Créteil, France
    • +1 more
    Jun 29, 2022

    Melanoma, BRAF V600 Mutation, Unresectable Melanoma Trial in Rennes (Binimetinib Oral Tablet)

    Completed
    • Melanoma
    • +3 more
    • Binimetinib Oral Tablet
    • Rennes, France
      Biotrial
    Mar 31, 2023

    BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer

    Recruiting
    • Metastatic Non-small Cell Lung Cancer
    • BRAF V600 Mutation
      • Lyon, Rhône Alpes, France
        CHU Lyon - Hôpital Cardio-Vasculaire et Pneumologique Louis Prad
      Sep 14, 2022

      NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • +32 more
      • (no location specified)
      Mar 30, 2023

      Advanced Melanoma Trial in China (HLX208)

      Recruiting
      • Advanced Melanoma
      • Peking, Beijing, China
      • +6 more
      May 1, 2022

      Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

      Not yet recruiting
      • Colorectal Cancer
      • +4 more
      • (no location specified)
      Aug 18, 2022

      NSCLC Trial in Shanghai (HLX208)

      Recruiting
      • NSCLC
      • Shanghai, China
        Shanghai chest hospital
      Jan 5, 2022

      NSCLC, RET Driver Mutation, BRAF V600 Mutation Trial in Guanzhou (Toripalimab, Nab paclitaxel, Pemetrexed)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +5 more
      • Toripalimab
      • +3 more
      • Guanzhou, Guangdong, China
        Guangdong Lung Cancer Institute, Guangdong Provincial People's H
      Apr 4, 2023

      Anaplastic Thyroid Cancer, ATC Trial in Shanghai (HLX208)

      Recruiting
      • Anaplastic Thyroid Cancer
      • ATC
      • Shanghai, China
        Fudan University Affiliated Oncology Hospital
      Dec 30, 2021

      Dabrafenib Plus Trametinib In Rare BRAF V600E Mutation-Positive

      Not yet recruiting
      • Rare Unresectable or Metastatic BRAF V600E Mutation-positive Solid Tumors
      • Non-investigational
      • (no location specified)
      May 11, 2023

      Dabrafenib in Combination With Trametinib as Adjuvant Treatment

      Recruiting
      • Melanoma
      • Zhengzhou, Henan, China
      • +6 more
      Mar 17, 2022

      Non Small Cell Lung Cancer Trial (HLX208+HLX10)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • HLX208+HLX10
      • (no location specified)
      Nov 30, 2022

      Cancer Trial (Dabrafenib, Trametinib)

      Not yet recruiting
      • Cancer
      • (no location specified)
      May 25, 2023

      Advanced Solid Tumor, BRAF V600 Mutation Trial in Nanchang, Jinan, Shanghai (ABM-1310)

      Not yet recruiting
      • Advanced Solid Tumor
      • BRAF V600 Mutation
      • Nanchang, Jiangxi, China
      • +2 more
      Aug 12, 2022

      Advanced Solid Tumor, BRAF V600 Mutation Trial in United States (ABM-1310, Cobimetinib)

      Recruiting
      • Advanced Solid Tumor
      • BRAF V600 Mutation
      • San Francisco, California
      • +3 more
      Dec 30, 2022

      Aspirin in Combination With Trametinib and Dabrafenib

      Not yet recruiting
      • NSCLC
      • +4 more
      • Combind asprin with Trametinib and Dabrafenib
      • (no location specified)
      Aug 4, 2023

      Melanoma, Adjuvant Trial (Dabrafenib and Trametinib, Dabrafenib, Trametinib)

      Available
      • Melanoma
      • Adjuvant
      • Dabrafenib and Trametinib
      • +2 more
      • (no location specified)
      Mar 1, 2022

      Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients

      Recruiting
      • Melanoma (Skin)
      • +2 more
        • Evora, Portugal
          Hospital Evora
        May 30, 2022

        Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

        Not yet recruiting
        • Colorectal Cancer
        • BRAF V600E Mutation Positive
        • Encorafenib Oral Capsule + Cetuximab
        • (no location specified)
        Jan 30, 2023

        Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)

        Recruiting
        • Melanoma Stage III
        • +2 more
        • Encorafenib Pill
        • +2 more
        • Tampa, Florida
          Moffitt Cancer Center
        May 27, 2022

        Solid Tumor Trial in Beijing, Zhengzhou, Hangzhou (HL-085, Vemurafenib)

        Recruiting
        • Solid Tumor
        • Beijing, Beijing, China
        • +3 more
        Jan 20, 2022

        Cancer, Melanoma Trial in Worldwide (Dabrafenib, Trametinib)

        Completed
        Has Results
        • Cancer
        • Melanoma
        • Guangzhou, Guangdong, China
        • +12 more
        Jan 4, 2022

        Small Cell Lung Carcinoma Trial (Dabrafenib, Trametininb)

        Available
        • Small Cell Lung Carcinoma
        • (no location specified)
        Aug 20, 2021